Prosus NV【PRX】銘柄情報

個人投資家向けのプロ仕様のツール。

プレミアム

通貨

42.945

買値

42.90

売値

43.25

出来高

3,699,011

42.795 日の範囲 44.125

28.08 52 週間の範囲 46.20

時価総額

123.232B

前日終値

44.11

始値

43.675

時刻

42.945

最終取引時間

財務取引量

VWAP

平均取引量 (3 か月)

4,074,159

発行済株式数

2,869,538,000

配当利回り

PER

18.65

1 株当たり利益 (EPS)

2.3

歳入

6.22B

純利益

6.61B

セクター

Internet Service Provider

業界

Internet Service Provider

ウェブサイト

www.prosus.com

本社

Amsterdam, North Holland, Nld

設立

Prosus NV is listed in the Internet Service Provider sector of the ユーロネクスト with ticker PRX. The last closing price for Prosus NV was 44.11 €. Over the last year, Prosus NV shares have traded in a share price range of 28.08 € to 46.20 €.

Prosus NV currently has 2,869,538,000 shares in issue. The market capitalisation of Prosus NV is 126.58 € billion. Prosus NV has a price to earnings ratio (PE ratio) of 18.65.

Par Pharmaceutical Companies to Report Fourth Quarter and Full Year 2009 Results on February 24, 2010

WOODCLIFF LAKE, N.J., Feb. 2 /PRNewswire-FirstCall/ -- Par Pharmaceutical Companies, Inc. (NYSE:PRX) announced today that it will host a...

MonoSol Rx and Strativa Pharmaceuticals Extend Strategic Relationship

Option to collaborate on three new products Relationship built on successful development of ondansetron oral soluble film currently under FDA...

Par Pharmaceutical Receives Final Approval to Market Generic Ultram(R) ER

Par to Begin Shipping Tramadol ER Immediately WOODCLIFF LAKE, N.J., Nov. 16 /PRNewswire-FirstCall/ -- Par Pharmaceutical Companies, Inc...

Par Pharmaceutical Reports EPS of $0.76 for Third Quarter 2009

Achieves Record Quarterly Gross Margin of $92 Million WOODCLIFF LAKE, N.J., Nov. 6 /PRNewswire-FirstCall/ -- Par Pharmaceutical Companies, Inc...

Par Pharmaceutical Receives Final Approval To Market Generic Starlix(R)

Par to Begin Shipping Nateglinide Immediately WOODCLIFF LAKE, N.J., Sept. 10 /PRNewswire-FirstCall/ -- Par Pharmaceutical Companies, Inc...

Par Pharmaceutical Reports EPS of $0.71 for Second Quarter 2009

Brand & Generic Business Units Drive Strong Earnings WOODCLIFF LAKE, N.J., Aug. 4 /PRNewswire-FirstCall/ -- Par Pharmaceutical Companies, Inc...

Par Pharmaceutical to Host Second Quarter 2009 Earnings Conference Call on August 4 at 9:00 am

WOODCLIFF LAKE, N.J., July 15 /PRNewswire-FirstCall/ -- Par Pharmaceutical Companies, Inc. (NYSE:PRX) announced today that it will host a...

MonoSol Rx and Strativa Pharmaceuticals Submit New Drug Application for Ondansetron Orally Dissolving Film Strip

WARREN, N.J., April 9 /PRNewswire/ -- MonoSol Rx, the developers of PharmFilm(R) technology and a drug delivery company specializing in...

MonoSol Rx Successfully Completes Pivotal Bioequivalence Studies for Ondansetron Thin Film NDA

Expects to File NDA with FDA in Early to Mid-2009 WARREN, N.J., Dec. 2 /PRNewswire/ -- MonoSol Rx, the developers of PharmFilm(R) technology and...

/C O R R E C T I O N -- Par Pharmaceutical Companies, Inc./

In the news release, Patrick G. LePore Elected to Board of Directors of Par Pharmaceutical Companies, Inc., issued earlier today by Par...

期間 †	前日比	前日比 %	始値	高値	安値	平均出来高	VWAP
1	0.34	0.798028400422	42.605	44.29	42.45	4551064	43.54132036	DE
4	1.57	3.79456193353	41.375	46.2	41.36	4239815	43.50589347	DE
12	4.6	11.9963489373	38.345	46.2	33.075	4074159	40.22538273	DE
26	2.995	7.49687108886	39.95	46.2	33.075	3533696	39.79637556	DE
52	14.06	48.6757832785	28.885	46.2	28.08	3115799	36.79119368	DE
156	-5.735	-11.7810188989	48.68	79.37	23.755	2722981	44.44501514	DE
260	-20.455	-32.2634069401	63.4	110	23.755	2496181	54.82315268	DE

PRX - Frequently Asked Questions (FAQ)

What is the current Prosus NV share price?

The current share price of Prosus NV is 42.945 €

How many Prosus NV shares are in issue?

Prosus NV has 2,869,538,000 shares in issue

What is the market cap of Prosus NV?

The market capitalisation of Prosus NV is EUR 126.58B

What is the 1 year trading range for Prosus NV share price?

Prosus NV has traded in the range of 28.08 € to 46.20 € during the past year

What is the PE ratio of Prosus NV?

The price to earnings ratio of Prosus NV is 18.65

What is the cash to sales ratio of Prosus NV?

The cash to sales ratio of Prosus NV is 19.82

What is the reporting currency for Prosus NV?

Prosus NV reports financial results in USD

What is the latest annual turnover for Prosus NV?

The latest annual turnover of Prosus NV is USD 6.22B

What is the latest annual profit for Prosus NV?

The latest annual profit of Prosus NV is USD 6.61B

What is the registered address of Prosus NV?

The registered address for Prosus NV is SYMPHONY OFFICES GUSTAV, MAHLERPLEIN 5, AMSTERDAM, NORTH HOLLAND, 1082 MS

What is the Prosus NV website address?

The website address for Prosus NV is www.prosus.com

Which industry sector does Prosus NV operate in?

Prosus NV operates in the INTERNET SERVICE PROVIDER sector

銘柄コード	株価	出来高
ALSRSSirius Media	0.0108 € (42.11%)	36.98M
DBVDBV Technologies	1.08 € (38.28%)	10.56M
ABOABO Group Environment NV	5.30 € (24.41%)	54.94k
MLOCTOctopus Biosafety	0.13 € (17.12%)	11.6k
MLIMLImalliance	0.30 € (15.38%)	310
ALCYBCybergun	0.0002 € (-33.33%)	256.04M
ALALOAcheterLouerFR	0.0018 € (-33.33%)	324M
TDBSTonner Drones	0.0044 € (-16.98%)	818.54k
MLIDSIds	0.30 € (-14.29%)	1.23k
ALVERVergnet	0.0007 € (-12.50%)	499.93M
ALVERVergnet	0.0007 € (-12.50%)	499.93M
ALALOAcheterLouerFR	0.0018 € (-33.33%)	324M
ATOAtos SE	0.004 € (-2.44%)	316.86M
ALCYBCybergun	0.0002 € (-33.33%)	256.04M
ALEUPEuroplasma	0.0149 € (1.36%)	101.8M

銘柄コード

株価

出来高